We’re excited to be part of Toronto Tech Week with a HealthTech panel + networking reception designed for real, candid conversation. Esplanade Ventures is co-hosting with Pender Ventures and Amplify Capital, bringing founders, investors, and the people who actually approve and buy healthtech into the same room to talk candidly about what moves deals forward (and what doesn’t). 🔗 Register here: https://luma.com/g7oj4jm7 (Space is limited - claim your spot early) ⏰ Thursday, May 28 | 2–4pm 📍 Luma Restaurant (Toronto) 🥂 Drinks included #TorontoTechWeek #TTW2026 #TorontoTech #ttw2026 #builtbytoronto #HealthTech #DigitalHealth #VentureCapital Dr. Sheldon Elman Ella Seitz Alexandre Nossovskoi Timothy S. Meryeme Lahmami Everett Juurlink Kathryn Wortsman Craig Hunter
Esplanade Ventures
Venture Capital and Private Equity Principals
Montreal, Quebec 2,678 followers
Our team invests and empowers visionary digital health companies
About us
Esplanade Ventures is an early-stage digital health venture fund. Initially formed in 2019 by the founders of Medisys Health Group and Persistence Capital Partners, Canada’s largest Healthcare Private Equity firm. Our team creates value using our deep healthcare knowledge, extensive network, active strategic direction, and key partnerships through distribution channels. We are led by owners and operators of healthcare businesses within Canada and globally with over 85 years of combined experience. Our team is working to establish a leading, interconnected digital health ecosystem that successfully scales portfolio companies to drive digital health innovation globally. We have offices in Montreal and Toronto.
- Website
-
https://esplanadeventures.com/
External link for Esplanade Ventures
- Industry
- Venture Capital and Private Equity Principals
- Company size
- 2-10 employees
- Headquarters
- Montreal, Quebec
- Type
- Partnership
- Founded
- 2019
Locations
-
Primary
Get directions
600 boulevard de maisonneuve o
Suite 2000
Montreal, Quebec H3A 3J2, CA
-
Get directions
181 Bay street
Suite 4260
Toronto, Ontario M5J 2T3, CA
Employees at Esplanade Ventures
Updates
-
We’re thrilled to congratulate our co-founding partner, Dr. Sheldon Elman, on his appointment as President of the Jewish General Hospital. This is a tremendous recognition of his leadership, vision, and long-standing commitment to driving innovation in healthcare. Under his guidance, the Jewish General Hospital is well positioned to accelerate transformative initiatives, advance cutting-edge care, and strengthen the impact of one of Canada’s premier medical institutions. A well-deserved milestone—congratulations, Sheldon! 👏 https://lnkd.in/gu_cCJ9w
-
Incredibly proud of what Laura Yecies and the team at Osteoboost Health developed to help women improve #BoneHealth and #womenshealth for #postmenopausal women
With six U.S. patents, commercial rollout underway, and validated outcomes from a pivotal 12-month trial, Osteoboost Health is building what the future of bone health should look like. An AgeTech Collaborative™ from AARP startup, Osteoboost offers the first and only FDA-cleared, drug-free prescription treatment for #osteopenia. Their wearable delivers precision vibration therapy to the hips and spine, areas most at risk of fractures. The results? Clinically proven. Led by seasoned healthtech CEO Laura Yecies (Catch, SugarSync) the team has: - FDA Class II medical device clearance - Completed pivotal trial at University of Nebraska Medical Center - New data presented at Endo 2025 showing 82% adherence and high usability - Nationwide U.S. launch as of May 2025 - Six U.S. patents protecting core vibration therapy technology - Backing from the National Institute on Aging (NIA) and lead investors including Esplanade Ventures, Terumo Medical Corporation, Ambit Health Ventures, Portfolia, Astia & Golden Seeds - A strategy focused on provider, patient, and reimbursement alignment What’s next: > Scaling adoption in women’s health and aging care > Expanding digital adherence tools and exercise programs > Building strategic clinical and distribution partnerships In a sector where safety and credibility are everything, Osteoboost is leading and opening up a new category in bone health intervention. Are you an angel investor looking to learn more? Contact: jazan@agetechcapital.com Michael Jaasma Pamela M. Peeke, MD, MPH, FACP, FACSM Priya Patel Amelia Hay Andy Miller Alan MacIntosh Bruce B. Simpson Lyne Landry, ICD.DJeremie Azan Christele Berthelot-Logsdon #AngelInvesting #Longevity #Healthspan #BoneHealth #ATIN #FDAApproved #AgeTech #DigitalHealth #Prevention #VibrationTherapy #WomenInHealthTech #NonPharma #PrecisionMedicine
-